Accuray - Bathi operasional EBITDA ARAY
Is it worth investing in Accuray Incorporated (ARAY), which seeks to capture the precision radiation niche through AI implementation and expansion into new markets? The time trajectory on the GURU.Markets chart for aggregated EBITDA provides the answer, where the value 11.27 represents the latest figure. Energy-efficient production and ESG supply chain audits, alongside maximum capacity utilization of robotic system plants without downtime, bolster the business's resilience.
Accuray (ARAY) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Accuray Incorporated|ARAY - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Accuray Inc|ARAY - Gunggung utang perusahaan|Utang marang nilai buku Accuray Incorporated|ARAY - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Accuray Incorporated|Rasio jangkoan perantara accuray.com
- statistik bathi lan rasio pasar:
ARAY - Bathi resik|Proyeksi bathi mangsa ngarep Accuray Incorporated|ARAY - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi accuray.com|ARAY - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Accuray Incorporated|ARAY - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Accuray Incorporated|ARAY - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan accuray.com|ARAY - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Accuray Incorporated
Ringkesan analitik perusahaan:ARAY - Accuray, Inc.
Analyzing the absolute EBITDA trend allows for an assessment of Accuray Incorporated (ARAY) within the radiosurgery sector through the lens of its ability to monetize the integration of AI into CyberKnife systems. This indicator captures the actual cash flow from core operations without depreciation distortions, where profit growth confirms the effectiveness of strategic alliances with radiology centers and the overall resilience of the business model.
Analisis pesaing Accuray Incorporated
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi operasional EBITDA erasca.com (ERAS)|Bathi operasional EBITDA DCTH (Delcath Systems)|YMAB - Bathi operasional sadurunge ngurangi amortisasi|Aura Bio - Bathi operasional EBITDA|Candel Therapeutics (CADL) - Bathi operasional sadurunge ngurangi amortisasi|SLS (sellaslifesciences.com) - Bathi operasional sadurunge ngurangi amortisasi|actuatetherapeutics.com (ACTU) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Citius Oncology|HURA: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TARA|Bathi operasional EBITDA Fate Pharma (FATE)|Aadi Bioscience - Bathi operasional sadurunge ngurangi amortisasi|TScan Therapeutics Inc (TCRX) - Bathi sadurunge bunga, pajak, lan amortisasi|CSBR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XBIT (XBiotech Inc.)|CVM: Bathi operasional EBITDA|OSTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Radiopharm Theranostics|Bathi operasional sadurunge amortisasi ARTV (Artiva)|Bathi operasional EBITDA ANL|Bathi operasional sadurunge ngurangi amortisasi Veru Inc VERU|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Xilio Therapeutics Inc (XLO) - Bathi sadurunge bunga, pajak, lan amortisasi|RENB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi MURA (Mural Oncology plc)|kairospharma.com (KAPA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi OKUR (OnKure Therapeutics)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CytoMed Therapeutics Ltd|Bathi sadurunge bunga, pajak, lan amortisasi Curis Corp CRIS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Apollomics, Inc. (APLM)|THAR (tharimmune.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ADVB (Advanced Biomed)|Bathi operasional EBITDA Genprex Inc. GNPX|CLDI: Bathi operasional sadurunge ngurangi amortisasi|sunshinebiopharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|XBIO: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi salariuspharma.com (SLRX)|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi AONC (AON)|Bathi operasional EBITDA BGNE|Bathi operasional EBITDA Checkpoint Therapeutics Inc (CKPT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ICAD|Ikena - Bathi operasional EBITDA|NTBL - Bathi operasional EBITDA|VIRX (viracta.com) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
